Vitamin K1 vs K2: Bone, Heart, and Which Form You Actually Need

Vitamin K comprises a family of fat-soluble compounds united by a naphthoquinone ring structure and a role as a cofactor for gamma-glutamyl carboxylase — the enzyme that activates vitamin K-dependent proteins by adding a carboxyl group to specific glutamic acid residues, enabling them to bind calcium. The two main dietary forms — K1 (phylloquinone) and K2 (menaquinones) — have dramatically different tissue distribution, half-lives, and clinical implications. Understanding the distinction is one of the most practically useful pieces of nutritional biochemistry for bone and cardiovascular health.

The Vitamin K-Dependent Proteins That Matter Most

Gamma-carboxylation activates a family of proteins with critical functions. In coagulation: factors II, VII, IX, and X, as well as protein C and protein S. This is the well-known warfarin mechanism — warfarin blocks vitamin K recycling, preventing carboxylation of clotting factors. In bone metabolism: osteocalcin (also called bone Gla protein, BGP) is produced by osteoblasts and, when fully carboxylated, binds calcium in hydroxyapatite crystals. Undercarboxylated osteocalcin (ucOC) — elevated when vitamin K is insufficient — is an independent predictor of fracture risk. In arterial tissue: matrix Gla protein (MGP) is produced by vascular smooth muscle cells and, when carboxylated, inhibits pathological calcium deposition in arteries. Undercarboxylated MGP is a reliable marker of arterial calcification and cardiovascular risk.

K1 vs K2: The Critical Difference

Phylloquinone (K1) is found in green leafy vegetables — kale, spinach, collards, broccoli. It is rapidly cleared from circulation (half-life ~1–2 hours) and is preferentially taken up by the liver for hepatic coagulation factor synthesis. Dietary K1 adequately maintains coagulation in healthy people but is less available to extrahepatic tissues like bone and arteries.

Menaquinones (K2) come in several subtypes distinguished by their side-chain length: MK-4 (found in animal fats, cheese, egg yolks, a short-chain form), MK-7, MK-8, MK-9 (found in fermented foods, particularly natto — Japanese fermented soybeans, which has extraordinarily high MK-7 content). MK-7 has a half-life of 72+ hours versus 1–2 hours for K1, producing sustained, stable blood levels. More importantly, K2 menaquinones — particularly MK-7 — are distributed to extrahepatic tissues including bone and arterial walls at substantially higher concentrations than K1. This is why K2 activates osteocalcin and MGP in ways that K1 does not meaningfully achieve.

K2 and Bone Health

The Rotterdam Study, a large prospective cohort, found that the highest tertile of dietary K2 intake (but not K1) was associated with a 57% lower risk of aortic calcification and significantly lower fracture risk. Japanese epidemiology consistently shows lower hip fracture rates in regions with high natto consumption.

Intervention trials are promising but heterogeneous. A 3-year Dutch RCT (VitaK-CAC Trial) testing MK-7 at 180 mcg/day found no effect on coronary calcification progression in healthy postmenopausal women (the study population may have been too healthy). However, a different 3-year Dutch trial in older women found MK-7 at 180 mcg/day significantly reduced the loss of bone mineral density and bone strength. Meta-analyses of K2 intervention trials generally show positive effects on bone mineral density and fracture rates, particularly in older women and in Japanese studies using pharmacological MK-4 doses (45 mg/day, used as a pharmaceutical in Japan).

K2 and Cardiovascular Health

The arterial calcification connection is mechanistically compelling. Inactive (undercarboxylated) MGP accumulates in atherosclerotic plaques and calcified arteries; activated MGP prevents calcification. The PROSPECT cohort found highest K2 dietary intake associated with 52% lower risk of coronary heart disease. The Matrix Gla Protein and K study (in kidney disease patients, who have severe vascular calcification) found K2 supplementation at 360 mcg MK-7/day significantly reduced vascular calcification markers.

The clinical question of whether K2 supplementation reduces hard cardiovascular endpoints (MI, death) in the general population is not yet answered by large RCTs. But the mechanistic and epidemiological evidence is strong enough to make K2 a rational addition for people at risk of vascular calcification, especially those taking vitamin D (which increases calcium absorption) without accompanying K2.

Dosing

For general supplementation: 90–200 mcg/day of MK-7. For specific bone or cardiovascular outcomes: 180–360 mcg/day of MK-7. Pharmacological MK-4 in Japan uses 45 mg/day (a prescription medication there). K1 requirements are met by eating green vegetables; a serving of cooked kale or spinach provides 400–600 mcg. No UL has been established for K2. K1 has a UL concern only in the context of warfarin therapy.

FAQ

Can I take vitamin K2 if I am on warfarin? Only with physician coordination. Warfarin works by blocking vitamin K recycling; K2 supplementation would directly antagonize warfarin's anticoagulant effect. Warfarin patients must maintain consistent vitamin K intake — dramatic changes in K intake destabilize INR. K2 supplementation without warfarin dose adjustment is contraindicated.

Does K2 work better with vitamin D? Yes — synergistically. Vitamin D increases production of osteocalcin and other K-dependent proteins; K2 activates them. High-dose vitamin D supplementation without K2 may increase calcium absorption and theoretically raise soft tissue calcification risk if MGP cannot be adequately activated. Co-supplementing with K2 (100–200 mcg MK-7) alongside vitamin D is a rational and increasingly common approach.

What is the best food source of K2? Natto is by far the richest source — a single 100g serving can contain 1,000 mcg of MK-7, several days worth at a time. Other sources: hard cheese (MK-8,9), soft cheese, egg yolks, butter, chicken breast and liver (MK-4). Fermented vegetables have variable but generally lower K2 content.

Related Articles

• Vitamin D: Optimal Dosing, K2, and What Most People Get Wrong
• B Vitamins: Morning or Night? The Science-Backed Answer
• Vitamin B12: Methylcobalamin vs Cyanocobalamin and Deficiency Guide
• Biotin: Hair, Nails, and the Evidence Behind the Hype
• Folate vs Folic Acid: Methylfolate, MTHFR, and Why It Matters

Track your supplements in Optimize.